Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial.

Abizaid A, Mehran R, Oliva A, Chamié D, Staico R, Malik F, Vink M, Kurniadi A, Cao D, Capranzano P, Faurie B, Garot P, Hildick-Smith D, Ielasi A, Löffelhardt N, Kedev S, Mylotte D, Milewski K, Paradies V, Schmitz T, Teeuwen K, Testa L, Toelg R, Vochelet F, Vogel B, Wykrzykowska J, Sartori S, Colombo A, Saito S, Morice MC, ABILITY Diabetes Global investigators

Open source

DOI: 10.1016/s0140-6736(25)02157-9
Published: 2026 Jan 17
Container: Lancet (London, England)
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-25-02157-9,
  title = {Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial.},
  author = {Abizaid A and Mehran R and Oliva A and Chamié D and Staico R and Malik F and Vink M and Kurniadi A and Cao D and Capranzano P and Faurie B and Garot P and Hildick-Smith D and Ielasi A and Löffelhardt N and Kedev S and Mylotte D and Milewski K and Paradies V and Schmitz T and Teeuwen K and Testa L and Toelg R and Vochelet F and Vogel B and Wykrzykowska J and Sartori S and Colombo A and Saito S and Morice MC and ABILITY Diabetes Global investigators},
  year = {2026},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(25)02157-9},
  url = {https://doi.org/10.1016/s0140-6736(25)02157-9}
}

RIS

TY  - JOUR
TI  - Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial.
AU  - Abizaid A
AU  - Mehran R
AU  - Oliva A
AU  - Chamié D
AU  - Staico R
AU  - Malik F
AU  - Vink M
AU  - Kurniadi A
AU  - Cao D
AU  - Capranzano P
AU  - Faurie B
AU  - Garot P
AU  - Hildick-Smith D
AU  - Ielasi A
AU  - Löffelhardt N
AU  - Kedev S
AU  - Mylotte D
AU  - Milewski K
AU  - Paradies V
AU  - Schmitz T
AU  - Teeuwen K
AU  - Testa L
AU  - Toelg R
AU  - Vochelet F
AU  - Vogel B
AU  - Wykrzykowska J
AU  - Sartori S
AU  - Colombo A
AU  - Saito S
AU  - Morice MC
AU  - ABILITY Diabetes Global investigators
PY  - 2026
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(25)02157-9
UR  - https://doi.org/10.1016/s0140-6736(25)02157-9
ER  -

APA

A, A., R, M., A, O., D, C., R, S., F, M., M, V., A, K., D, C., P, C., B, F., P, G., D, H., A, I., N, L., S, K., D, M., K, M., V, P., T, S., K, T., L, T., R, T., F, V., B, V., J, W., S, S., A, C., S, S., MC, M., & investigators, A. D. G. (2026). Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(25)02157-9

Source records

pubmed · retrieved 2026-09-26T00:51:24.328Z
europe-pmc · retrieved 2026-09-26T00:51:24.342Z